Click Therapeutics, Inc.

Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia

Role: lead

An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia

Role: lead

Exploratory Study of a Digital Therapeutics in People With Schizophrenia

Role: lead

Study of Two Digital Therapeutics for the Prevention of Episodic Migraine

Role: lead

7-week Study With CT-155 in People With Schizophrenia

Role: lead

Ecological Momentary Assessment and Text Message Intervention for Stress Management

Role: lead

A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia

Role: lead

An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis

Role: lead

An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia.

Role: lead

Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)

Role: lead

Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder

Role: collaborator

An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

Role: lead

Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training

Role: lead

Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms

Role: lead

Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification

Role: lead

Clinical Learning Study for a Mobile Smoking Cessation Program

Role: lead

Clinical Trial of Smoking Cessation Mobile Phone Program

Role: lead